Abstracts - faqs.org

Abstracts

Business, general

Search abstracts:
Abstracts » Business, general

Mylan Laboratories

Article Abstract:

A comparative analysis of the company sales and earnings and the financial details of Mylan Laboratories from 1988 - 2003 are illustrated. Projections of the equity price of this company for 2004 - 2005 is made using Value Line estimates.

Author: Butler, Jeremy J.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2004
Sales, profits & dividends, Company sales and earnings, Company earnings/profit, Mylan Laboratories Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Drug industry

Article Abstract:

The stock price stability, future earning prospects and financial strength of various pharmaceutical companies in the United States are analyzed.

Author: Rho, George, Romaine, Sigourney B., Schlein, Milton, Clark, Charles, Butler, Jeremy J., Markey, Keith A., Rosner, Adam, Harris, Frederick L., Ferrara, Susan J., Antonson, Erik A., Napoli, Michael F., Maurer, Douglas G.
Publisher: Value Line Publishing, Inc.
Publication Name: The Value Line Investment Survey (Part 3 - Ratings & Reports)
Subject: Business, general
ISSN: 0042-2401
Year: 2007
Forecasts, trends, outlooks, Sales & consumption, Industry sales and revenue, Industry forecasts

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA



Subjects list: United States, Pharmaceutical industry, Securities, Company securities
Similar abstracts:
  • Abstracts: Aventis. Drug industry
  • Abstracts: IVAX Corp. Drug industry. Ivax Corp
  • Abstracts: Drug industry. Merck and Co
  • Abstracts: Medarex Inc. Medarex, Inc
  • Abstracts: MedImmune Inc. Cyberonics, Inc
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.